Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Compensated Cirrhosis”

141 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 141 results

Large-scale testing (Phase 3)Study completedNCT00687219
What this trial is testing

Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116)

Who this might be right for
Hepatitis C, ChronicLiver Cirrhosis
Merck Sharp & Dohme LLC 102
Early research (Phase 1)Looking for participantsNCT05484206
What this trial is testing

Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434

Who this might be right for
Hepatic ImpairmentCirrhosis
Vir Biotechnology, Inc. 144
Testing effectiveness (Phase 2)Ended earlyNCT04267393
What this trial is testing

Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Bristol-Myers Squibb 124
Testing effectiveness (Phase 2)Ended earlyNCT05161481
What this trial is testing

Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Who this might be right for
Hypertension, Portal
Boehringer Ingelheim 80
Testing effectiveness (Phase 2)Study completedNCT01995071
What this trial is testing

Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)

Who this might be right for
Chronic Hepatitis CHepatitis C VirusCompensated Cirrhosis
AbbVie 89
Large-scale testing (Phase 3)Study completedNCT02966795
What this trial is testing

Of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 84
Large-scale testing (Phase 3)Study completedNCT02023112
What this trial is testing

Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus
AbbVie 171
Early research (Phase 1)Study completedNCT04950764
What this trial is testing

An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

Who this might be right for
Primary Biliary CholangitisCompensated CirrhosisHepatic Impairment
Gilead Sciences 24
Large-scale testing (Phase 3)Study completedNCT02247401
What this trial is testing

Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt

Who this might be right for
HCVHepatitis C InfectionGenotype 4
AbbVie 160
Testing effectiveness (Phase 2)Ended earlyNCT01672879
What this trial is testing

Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH

Who this might be right for
Liver Fibrosis Due to NASH
Gilead Sciences 259
Large-scale testing (Phase 3)Study completedNCT03069365
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 101
Not applicableUnknownNCT04975477
What this trial is testing

CHESS-SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102)

Who this might be right for
Compensated Advanced Chronic Liver Disease
Hepatopancreatobiliary Surgery Institute of Gansu Province 1,000
Testing effectiveness (Phase 2)Study completedNCT01685203
What this trial is testing

Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
AbbVie (prior sponsor, Abbott) 316
Large-scale testing (Phase 3)Ended earlyNCT03053063
What this trial is testing

Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 883
Not applicableUnknownNCT04160897
What this trial is testing

Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis

Who this might be right for
Hepatitis B, ChronicHepatocellular CarcinomaCompensated Cirrhosis
Qing XIe 4,000
Large-scale testing (Phase 3)WithdrawnNCT02824354
What this trial is testing

Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.

Who this might be right for
CirrhosisAlcohol DependenceNalmefene
Centre Hospitalier Universitaire, Amiens
Not applicableLooking for participantsNCT07122622
What this trial is testing

2D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices

Who this might be right for
Portal Hypertension Related to CirrhosisEsophageal Varices
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 450
Not applicableNot Yet RecruitingNCT06537466
What this trial is testing

Ketogenic Diet in MASLD-related cACLD

Who this might be right for
Steatohepatitis, NonalcoholicSteatosis of LiverCirrhosis, Liver
University of Palermo 50
Not applicableUnknownNCT04281303
What this trial is testing

Endoscopic Bariatric Therapy in NASH Cirrhosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Instituto de Investigación Marqués de Valdecilla 10
Large-scale testing (Phase 3)Study completedNCT01973049
What this trial is testing

UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 202
Load More Results